PubRank

Oliver Neuhaus

Author PubWeight™ 18.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 2012 3.12
2 Acute disseminated encephalomyelitis: an update. Arch Neurol 2005 2.45
3 Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 2002 2.02
4 Glatiramer acetate: evidence for a dual mechanism of action. J Neurol 2008 1.49
5 Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis. Arch Neurol 2009 1.42
6 Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action. CNS Drugs 2011 1.15
7 Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires. J Immunol 2005 1.06
8 Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol Sci 2007 0.96
9 Statins in the treatment of central nervous system autoimmune disease. J Neuroimmunol 2006 0.91
10 Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. J Neuroimmunol 2004 0.89
11 Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS. Exp Neurol 2007 0.81
12 Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy. J Neurol Sci 2005 0.79
13 Bimanual recoupling by visual cueing in callosal disconnection. Neurocase 2004 0.79
14 Postinfectious immunodeficiency and autoimmunity: pathogenic and clinical values and implications. Expert Rev Clin Immunol 2007 0.77
15 The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis. J Neuroimmunol 2003 0.75
16 Statins as potential therapeutic agents in multiple sclerosis. Curr Neurol Neurosci Rep 2004 0.75
17 New diagnostic options in tuberculous meningitis? Int J Tuberc Lung Dis 2006 0.75